187 related articles for article (PubMed ID: 26273160)
21. Case Report: Successful Treatment of Acute Generalized Exanthematous Pustulosis With Secukinumab.
Zhang L; Xu Q; Lin T; Ruan S; Lin M; Bao C; Zhang J; Liu T; Gong T; Ji C
Front Med (Lausanne); 2021; 8():758354. PubMed ID: 34993208
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US.
Creadore A; Desai S; Alloo A; Dewan AK; Bakhtiar M; Cruz-Diaz C; Femia A; Fox L; Katz KL; Micheletti R; Nelson CA; Ortega-Loayza AG; Patrinely JR; Plovanich M; Rosenbach M; Shaigany S; Shields BE; Saleh JZ; Sharif-Sidi Z; Shinkai K; Smith J; Su C; Wanat KA; Wieser JK; Wright S; Noe MH; Mostaghimi A
JAMA Dermatol; 2022 Feb; 158(2):176-183. PubMed ID: 34985493
[TBL] [Abstract][Full Text] [Related]
23. Acute generalized exanthematous pustulosis: Epidemiology, clinical course, and treatment outcomes of patients treated in an Asian academic medical center.
Oh DAQ; Yeo YW; Choo KJL; Pang SM; Oh CC; Lee HY
JAAD Int; 2021 Jun; 3():1-6. PubMed ID: 34409363
[TBL] [Abstract][Full Text] [Related]
24. Clinical features of acute generalized exanthematous pustulosis caused by hydroxychloroquine in rheumatology patients and exploration of
Luo F; Yuan XM; Xiong H; Yang YZ; Chen CM; Ma WK; Yao XM
Front Med (Lausanne); 2023; 10():1161837. PubMed ID: 37089611
[TBL] [Abstract][Full Text] [Related]
25. Terbinafine-induced acute generalized exanthematous pustulosis (AGEP) responsive to high dose intravenous corticosteroid.
Ibrahimi OA; Gunawardane N; Sepehr A; Reynolds RV
Dermatol Online J; 2009 Sep; 15(9):8. PubMed ID: 19930995
[TBL] [Abstract][Full Text] [Related]
26. Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.
Vallejo-Yagüe E; Martinez-De la Torre A; Mohamad OS; Sabu S; Burden AM
J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054090
[TBL] [Abstract][Full Text] [Related]
27. The necessity of patch testing in determining the causative drug of AGEP.
Mofarrah R; Mofarrah R; Oshriehye M; Ghobadi Aski S; Nazemi N; Nooshiravanpoor P
J Cosmet Dermatol; 2021 Jul; 20(7):2156-2159. PubMed ID: 33190407
[TBL] [Abstract][Full Text] [Related]
28. Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis.
Tajmir-Riahi A; Wörl P; Harrer T; Schliep S; Schuler G; Simon M
Int Arch Allergy Immunol; 2017; 174(2):108-111. PubMed ID: 29065395
[TBL] [Abstract][Full Text] [Related]
29. Five-Year Retrospective Review of Acute Generalized Exanthematous Pustulosis.
Thienvibul C; Vachiramon V; Chanprapaph K
Dermatol Res Pract; 2015; 2015():260928. PubMed ID: 26783390
[TBL] [Abstract][Full Text] [Related]
30. Acute generalized exanthematous pustulosis (AGEP): A review and update.
Szatkowski J; Schwartz RA
J Am Acad Dermatol; 2015 Nov; 73(5):843-8. PubMed ID: 26354880
[TBL] [Abstract][Full Text] [Related]
31. Acute generalized exanthematous pustulosis: Analysis of cases managed in a Tunisian tertiary hospital.
Fathallah N; Kenani Z; Mokni S; Gammoudi R; Slim R; Fetoui Ghariani N; Ghariani N; Ben Salem C; Ouni B; Denguezli M
Therapie; 2023 Dec; ():. PubMed ID: 38142193
[TBL] [Abstract][Full Text] [Related]
32. Severe flucloxacillin-induced acute generalized exanthematous pustulosis (AGEP), with toxic epidermal necrolysis (TEN)-like features: does overlap between AGEP and TEN exist? Clinical report and review of the literature.
van Hattem S; Beerthuizen GI; Kardaun SH
Br J Dermatol; 2014 Dec; 171(6):1539-45. PubMed ID: 24888401
[TBL] [Abstract][Full Text] [Related]
33. Acute generalized exanthematous pustulosis with lymphangitis triggered by a spider bite.
Ermertcan AT; Demirer O; Inanir I; Bilaç C; Temiz P
Cutan Ocul Toxicol; 2010 Mar; 29(1):67-9. PubMed ID: 20001785
[TBL] [Abstract][Full Text] [Related]
34. Fluconazole-induced acute generalized exanthematous pustulosis.
Di Lernia V; Ricci C
Indian J Dermatol; 2015; 60(2):212. PubMed ID: 25814733
[TBL] [Abstract][Full Text] [Related]
35. Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer.
Komiya N; Takahashi K; Kato G; Kubota M; Tashiro H; Nakashima C; Nakamura T; Iwanaga K; Kimura S; Sueoka-Aragane N
Case Rep Oncol; 2021; 14(1):599-603. PubMed ID: 33976640
[TBL] [Abstract][Full Text] [Related]
36. Probable fenofibrate-induced acute generalized exanthematous pustulosis.
Power AE; Graudins LV; McLean CA; Hopper I
Am J Health Syst Pharm; 2015 Dec; 72(23):2061-3. PubMed ID: 26581932
[TBL] [Abstract][Full Text] [Related]
37. A Case of Vancomycin-induced Acute Generalized Exanthematous Pustulosis Confirmed by Patch Testing.
Pettit C; Trinidad J; Kaffenberger B
J Clin Aesthet Dermatol; 2020 Nov; 13(11):35-36. PubMed ID: 33282101
[TBL] [Abstract][Full Text] [Related]
38. Acute generalized exanthematous pustulosis with airway mucosa involvement: A case report.
Li LL; Lu YQ; Li T
World J Clin Cases; 2020 Aug; 8(16):3578-3582. PubMed ID: 32913867
[TBL] [Abstract][Full Text] [Related]
39. Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.
Atak MF; Farabi B; Akbayrak A; Kalelioğlu MB; Rao BK
J Cosmet Dermatol; 2021 Aug; 20(8):2387-2389. PubMed ID: 34139069
[No Abstract] [Full Text] [Related]
40. Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996-2013.
Alniemi DT; Wetter DA; Bridges AG; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT
Int J Dermatol; 2017 Apr; 56(4):405-414. PubMed ID: 28084022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
